Intravitreal injection of ranibizumab for foveal-macular pattern dystrophy: case report

Arquivos Brasileiros de Oftalmologia

Alexandre Augusto Cabral De Mello Ventura²  Lorna Winifred Grant¹  Hajir Dadgostar¹  Hilel Lewis¹ 

[1] ,Hospital de Olhos Santa Luzia Retina Departament Recife PE ,Brazil

关键词: Fovea centralis;    Lutein;    Retinal pigments;    Tomography;    optical coherence;    Macula lutea;    Macular degeneration;    Fluorescein angiography;    Choroidal neovascularization;    Antibodies;    monoclonal;    Intravitreal injections;    Fóvea central;    Luteína;    Pigmentos da retina;    Tomografia de coerência óptica;    Macula lútea;    Degeneração macular;    Angiofluoresceinografia;    Neovascularização de coroide;    Anticorpos monoclonais;    Injeções intravítreas;   

DOI  :  10.1590/S0004-27492011000400013

来源: SciELO

【 摘 要 】

In the recent years, anti-angiogenic medications have successfully treated other diseases associated with choroidal neovascularization. The anti-angiogenic therapy alone or combined with LASER and/or steroids has been effective in controlling ocular neovascularization, not only restricted to the treatment of typical membranes due to macular degeneration in the wet form. The discovery and subsequent use of these drugs has revolutionized medicine and ophthalmology. This report illustrates an example of successful treatment in a challenging pathology where it was found important visual and anatomical response after the use of ranibizumab.

【 授权许可】

CC BY   
 All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License